Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/4/12  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Martin S. Kleckner III

Wrong Martin S. Kleckner III?
 
Background

Employment History

  • Managing Principal
    La Costa Group LLC
  • Senior Vice President of Business Development
    RegeneMed
  • Co-Founder and Chief Executive Officer
    U P Laboratories
  • Chief Operations Officer
    NICHOLAS CONOR INSTITUTE
  • Senior Vice President for Business Development
    InSilicoMed
  • Senior Vice President Business and Market Development
    InSilicoMed
  • Co-founder and Chief Business Officer and Co-founding Member
    Salvino-Flex LLC
  • Vice President of Development
    Science and Engineering Associates
  • Director of Development
    Science and Engineering Associates
  • Chief Executive Officer; Business Development - Commercialization
    U P Technologies
  • Managing Principal
    Costa Group, LA
  • Consultant
    TOTAL INNOVATIONS GROUP INC
  • Medical Economist
    Roche
  • Healthcare Economist
    Roche

Board Memberships and Affiliations

Education

  • MBA
    University of California , Los Angeles
  • PhD , Public Policy
    University of California , Riverside
  • Bachelor of Arts ( BA , public policy and economics
    Whittier College
13 Total References
Web References
FLEX PARTNERS, INC. - Bio's - Martin Kleckner, III - Director, Business Development
www.flex-partners.com, 21 Oct 2005 [cached]
Martin Kleckner
...
Martin Kleckner
solutions ... ideasBio's - Martin Kleckner, III - Director, Business Development
Mr. Kleckner has twenty four (24) years experience in strategic planning, business development, operations and financial management.His background comprises heavy experience in development and management of internal operations, corporate strategies, and conditions impacting company performances.
Mr. Kleckner is the founder of La Costa Group, LLC www.lacostagroup.com, a multi-partner consultancy based in Carlsbad, California where he has assisted over 65 companies, both emerging businesses and Fortune 100 corporations with new technology commercialization, capitalization, general management, strategic planning and business development.He has taught programs in sales & marketing, finance, and business economics throughout Europe, Asia and the Americas for several companies including General Electric, Honeywell, Allied Signal, Roche Diagnostics, Toshiba America Medical, AGFA, Fuji Medical, and Hewlett Packard.Before founding La Costa Group, he was Director of Venture Development & Contract Executive at American Healthcare Systems where he was responsible for medical device market growth alliances.At Times Mirror Cable Systems, he served senior positions in finance and marketing and was General Manager for a $17 million division where he had full profit and loss accountability with 155 employees, leading it as the highest financially performing division in 1985 & 1986.He is a former legislative advocate representing businesses in the California state legislature & Washington D.C.
Mr. Kleckner earned his MBA from the University of California, Los Angeles (UCLA), an MA in Public Policy from the University of California, Riverside, and holds a BA from Whittier College.He has completed all Ph.D. requirements except dissertation from the University of California and received a certificate in healthcare executive management from the University of California, San Diego.He is a frequent lecturer at national conferences and regularly contributes articles to medical industry journals.
TNCI Management
www.thenicholasconorinstitute.org, 14 June 2013 [cached]
Martin S. Kleckner III PhD MBA- Chief Operations Officer
...
Martin S. Kleckner III PhD MBA - Chief Operations Officer Martin has served in the life sciences industry for over twenty (20) years. Prior to TNCI, he was co-founder and Chief Executive Officer for U P Laboratories in San Diego for the production of proprietary patented synthetic peptides (Excitation Secretion Uncoupling Peptides - ESUP) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis. Earlier, he was Senior Vice President for Business Development at InSilicoMed, a start-up company providing bioengineering simulation tools for cardiology and ophthalmic therapy applications; Senior Vice President of Business Development for RegeneMed, a company creating three-dimensional (3D) liver tissue for drug discovery applications; Co-founder and Chief Business Officer/Co-founding member for Salvino-Flex LLC wherein he facilitated the research and development of a chest tube insertion device, eventually selling the company.
He also was Vice President of Development for Science and Engineering Associates for the research and commercialization of theranostics applications in cervical and ovarian cancer. Martin has further served as medical economist for Roche, Respironics, and Toshiba America plus was the co-founder/CEO of a counter-intelligence device which as showcased worldwide on BBC, NBC, ABC, CBS and Fox - receiving an 11-minute lead story, and then helped solve a crime in a 2004 episode of CSI Miami.
La Costa Group, LLC - Corporate Solutions, Business Development, Strategy
www.lacostagroup.com, 13 Dec 2011 [cached]
Martin Kleckner, III PHD MBA concentrates on business development, commercialization, capitalization and mentoring of life science start-up ventures including 501(3)c not-for-profit initiatives. His background comprises 26 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
Mr. Kleckner's work comprises a heavy emphasis on business & market development for healthcare companies and hospital systems. He guides corporations worldwide on the formation of effective business alliances with hospital systems and GPOs. He specializes in healthcare economics, quality of care, clinical outcomes, operations design & development, sales and market development, cost & productivity and business alliance management initiatives. Experience includes six-sigma process facilitation; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, and operations management models.
He is currently serving as Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc. , specializing in the translation of new molecular biology (genomics and proteomics) diagnostics and treatments.
Martin Kleckner Picture ...
www.tritechsbdc.org [cached]
Martin Kleckner Picture v2
...
Martin Kleckner
Senior Business Consultant
...
Mr. Kleckner's background comprises 26 years on senior level operations, general management, marketing and business development in the life sciences, oil & gas, cable television, counter-intelligence and aerospace. His current work encompasses guiding emerging and established companies with corporate planning and strategy, commercialization and business development, marketing, and public policy throughout Europe, Asia & the Americas.
He is a co-founder of RefluxMD.com, a Health 2.0 Internet company specializing in gastroesophageal reflux disease. He further provides commercialization advisory support to the National Institutes of Health, Drexel Foundation, and Coulter Foundation with regard to awarded grants plus "Go/No-Go" grant funding decisions. He was previously Chief Operations Officer for The Nicholas Conor Institute for Pediatric Cancer Research, Inc., a 501 (c) 3 not-for-profit enterprise specializing in the translation and advancement of new molecular biology (genomics and proteomics) diagnostics and treatments via foundation and corporate life science partnerships.
Previously he was Chief Executive Officer for U P Laboratories in San Diego for the development of proprietary synthetic peptides (excitation secretion uncoupling peptides) as an alternative to botulinum neurotoxin (BoTox®) for topical anti-aging/wrinkle inhibition and hyperhidrosis. Earlier he was Senior Vice President for Business Development at InSilicoMed, a start-up company providing bioengineering simulation tools for cardiology and ophthalmic therapy applications; Senior Vice President of Business Development and angel investor for RegeneMed, a company creating three dimensional (3D) engineered liver tissue for drug discovery and bio-artificial liver support; co-founder and Chief Business Officer for Salvino-Flex LLC wherein he managed the research and development of a chest tube insertion device, ultimately selling the company. He was also Director of Development for Science and Engineering Associates for the commercialization of a diagnostic technology applicable to cervical, ovarian and oral/pharyngeal cancers.
He has further served as healthcare economist for Roche, Respironics, Toshiba Medical, and Terumo Interventional while also teaching courses for General Electric at its Crotonville, New York campus. He was the co-founder/CEO of a counter-intelligence device which was showcased worldwide on BBC, NBC, CBS and Fox (receiving an 11-minute lead story) and then was used to help solve a crime in a May 2004 episode of 'CSI Miami'. Previously he was Director of Venture Development/Contracts Executive with American Healthcare Systems serving in the starting group growing the company to $45 million in annual revenue eventually selling to Premier, Inc. He was General Manager for Times Mirror with direct responsibility for its leading cable television performer (a $19 million division), and launched a nationwide initiative for cable system reorganization, mergers, swaps, and divestitures eventually leading to sale of the remaining company to Cox Communications. Finally he was Corporate Planning Analyst for Berry Industries and California Shipbuilding specializing in mergers and acquisitions plus served as legislative advocate in the California state Senate and Assembly and Washington DC.
Mr. Kleckner's education consists of an MBA from the University of California, Los Angeles (UCLA) Anderson School; a PhD in Public Policy from the University of California, Riverside; a certificate in public health from the University of California, San Diego (UCSD); and a Bachelor of Arts (BA) with concentrations in public policy and economics from Whittier College.
The International Group, Inc.
www.tigi.net, 1 June 2009 [cached]
MARTIN KLECKNER III, PhD, MBA, MA - Consultant
Martin Kleckner's work comprises a heavy emphasis on strategic planning, healthcare economics, cost & productivity, and business development for healthcare systems and corporations. He specializes in healthcare economics, strategic planning and execution, quality of care, clinical outcomes, hospital cost & productivity and business alliance management initiatives via six sigma process facilitation, focused studies and analytics; medical technology cost effectiveness & economic impact studies, work flows analyses, process mapping, sales and market development tools, operations management models. He guides healthcare corporations worldwide on the formation of effective business alliances with hospital systems and GPOs. Major current work comprises capital equipment planning, procurement & logistics for hospital design and development and the formation of healthcare system/university alliances for accelerated BSN and LPN-BSN programs.
Mr. Kleckner is a member of California's Tech Coast Angels concentrating on business development, capitalization and mentoring of life science start-up ventures. His background comprises 27 years guiding emerging and Fortune 100 companies with new technology commercialization throughout Europe, Asia & the Americas.
He is currently serving as investor, advisor and Business Development Officer for RegeneMed, specializing in 3-D engineering of human liver tissue for drug research & discovery and disease therapies. He is a co-founder of Salvino-Flex LLC, launching a cardio-thoracic device for emergency-trauma applications; and a co-founder with Source Atlantic, specializing in capital equipment planning, high volume procurement and logistics for new hospital construction world-wide. Earlier medical ventures include diagnostic and therapy approaches for oral, pharyngeal, cervical and ovarian cancers.
Previously he was Founder and CEO of a venture for counter-surveillance technology, receiving worldwide coverage by NBC, CBS, FOX, and the BBC.
Other People with the name "Kleckner":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304